Agilent Technologies (A) has disclosed a new risk, in the Innovation / R&D category.
Agilent Technologies faces significant business risk as it integrates artificial intelligence into its operations and products. The nascent stage of AI development within the life sciences sector brings the possibility of deploying flawed or biased algorithms, which could lead to competitive disadvantage, regulatory sanctions, or legal challenges. Additionally, the ever-evolving regulatory landscape surrounding AI presents uncertainties that may affect Agilent’s ability to comply effectively, potentially exposing the company to further regulatory risks. Inadequate governance of AI could also introduce unforeseen vulnerabilities, threatening the integrity and reputation of Agilent Technologies.
The average A stock price target is $141.67, implying 7.82% upside potential.
To learn more about Agilent Technologies’ risk factors, click here.
